Response to “Clinical relevance of venlafaxine ER for generalized anxiety disorder”

Key Points

• Venlafaxine ER demonstrates notable effectiveness in treating generalized anxiety disorder, improving patient outcomes.
• Key evidence shows that patients experience significant symptom relief when treated with venlafaxine ER over six weeks.
• This observational analysis reviews clinical outcomes associated with venlafaxine ER for anxiety, providing essential insights for practitioners.
• The findings highlight the need for broader utilization of venlafaxine ER in treating generalized anxiety disorder, potentially enhancing patient care.

Abstract